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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S149cartilage extracellular matrix (ECM). Pro-inﬂammatory signaling con-
tributes to the degradation of the cartilage matrix. Under OA conditions,
synoviocytes produce a range of inﬂammatory mediators, including IL-
1b. Upon binding to chondrocytes, these mediators activate speciﬁc
signal transduction cascades, such as the nuclear factor-kappa-B (NF-
kB) pathway, which acts as one central regulator of the catabolic pro-
cesses that suppresses the synthesis of ECM components, and induces
the expression of matrix metalloproteinases and enzymes of the
ADAMTS family, leading to perpetuated cartilage breakdown.
This study aimed to evaluate the effects of brazilin in osteoarthritic
chondrocytes and synoviocytes with particular focus on the NF-kB
pathway.
Methods: Brazilin was isolated from Caesalpinia sappan extract (CSE)
and identiﬁed using HPLC and NMR methods. Chondrocytes and syn-
oviocytes were isolated from OA patients undergoing total knee
replacement surgery. Cells were either left untreated for control sam-
ples, were treated with 10 ng/ml IL-1b, or were pre-treated with 10 mg/
ml brazilin prior to the addition of 10 ng/ml IL-1b. Genes associated
with NF-kB-mediated signal transduction were examined in primary
human chondrocytes using an NF-kB signaling array and in silico
pathway analysis. The induction and inhibition of NFKB1, its gene
product p50, and the precursor p105 were investigated in primary
human chondrocytes and synoviocytes using RT-qPCR and Western
blotting.
Results: Nine NF-kB pathway-related genes (BIRC3, CCL2, CSF1, CSF3,
IL1B, IL8, NFKB1, NFKB2 and TNFAIP3) were found to be signiﬁcantly up-
regulated by IL-1b-stimulation and signiﬁcantly down-regulated after
pre-incubation with brazilin. Pathway analysis revealed NFKB1 as one
major gene regulating the anti-inﬂammatory activities of brazilin. RT-
qPCR assays conﬁrmed that the up-regulation of NFKB1 mRNA in IL-1b-
stimulated primary chondrocytes and synoviocytes was signiﬁcantly
reduced by pre-treatment with brazilin. Western blotting showed that
IL-1b treatment increased p105 protein in chondrocytes with a peak
after 1 h followed by a steady decline, while increasing constantly the
amount of p50 over 24 h. Brazilin suppressed the IL-1b-mediated
induction of NFKB1/p50 in chondrocytes and synoviocytes.
Conclusions: The present study suggests that brazilin effectively blocks
the induction of NFKB1/p50 in cytokine-stimulated primary human
chondrocytes and synoviocytes, pointing towards a chondroprotective
potential of brazilin, which may be beneﬁcial for reducing cartilage
breakdown in OA.
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EFFECT OF BONE MARROW SURGICAL APPROACH AND RAPIDLY
DEGRADING PRESOLIDIFIED SUBCHONDRAL CHITOSAN/BLOOD
IMPLANT ON RESURFACING OF CHONDRAL DEFECTS IN A SHEEP
MODEL
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Purpose: Bone marrow stimulation for cartilage repair is partly limited
by inadequate stem cell recruitment from the trabecular bone marrow
to the cartilage lesion. We tested the hypothesis that the cartilage repair
elicited by marrow stimulation can be improved by subchondral
delivery of rapidly degrading pre-solidiﬁed chitosan/blood implants to
bone defects with free communication with the trabecular bone mar-
row. Jamshidi needles and a drill burr were used to create 2mm
diameter bone defects with cleanly removed bone to maximize cell
recruitment.
Methods: Full-thickness 10x10mm cartilage defects were created in the
medial femoral condyle in both knees of 11 mature sheep. Based on a
pre-planned template, three 2-mm diameter bone holes were gen-
erated systematically at the corner of each defect with a Jamshidi biopsy
needle and a drill burr, and the area between the holes was perforated
with six smaller microfracture holes (Fig. 1A-B). 10 kDa chitosan/
autologous whole blood implant was presolidiﬁed ex vivo with coag-
ulation factor (recombinant human Factor VIIa, rhFVIIa, or Tissue Factor,
TF) and inserted into each of the three 2-mm diameter holes. Con-
tralateral control defects were treated with whole blood presolidiﬁed
with rhFVIIa or TF. Day 1 (N ¼ 1) and 6.5 month repair (N ¼ 10) was
evaluated bymacroscopic scoring, andmicro-CT, histomorphometry for
collagen type I and II, and histological scoring (ICRS-2). Four intact age-
matched condyles were micro-CT scanned for baseline bone parame-
ters. 6.5 month cartilage repair tissues were also analyzed bybiochemistry for glycosaminoglycan (GAG) and collagen (% weight per
wet weight). The General Linear Model (Statistica, Statsoft, V6.2, NB,
USA) was used to analyze differences due to surgical approach (drill
hole vs 2 averaged Jamshidi holes per defect, N ¼ 20, vs intact condyles
N ¼ 4) and differences due to implant condition (N ¼ 10). p < 0.05 was
considered signiﬁcant.
Results: At day 1 post-operative, the marrow stimulation approach led
to a 65% decrease in the subchondral bone volume fraction (BVF, %)
compared to intact condyles, along with extensive subchondral bleed-
ing (Fig. 1A-D). Rapidly degrading chitosan implant was retained near
the surface of the bone defects at day 1, with no signiﬁcant effects on
bone or cartilage repair features at 6.5 months. At 6.5 months post-
operative, most medial femoral condyles (but not lateral femoral con-
dyles) developed large osteophytes. Only modest subchondral bone
repair was observed in the defect area (13% increase in BVF compared to
acute defects), and in 3 out of 20 defects, net bone resorption around
the Jamshidi biopsy hole was observed (Fig. 1G). The larger 2mm bone
holes were consistently resurfaced with collagen type II repair with
higher collagen content (18% vs 15% w/w) and lower GAG (2.4% vs 4.4%
w/w) than tissue outside the defect, while shallow microfracture holes
were poorly resurfaced (Fig. 1F). Compared to Jamshidi biopsy holes,
drill burr elicited a higher overall cartilage repair histological quality (33
 28 vs 49  25, p ¼ 0.041, N ¼ 20 marrow stimulation holes, Fig. 1H-I).
Conclusions: Blood vessels sheared by Jamshidi surgical marrow
stimulation can devitalize the subchondral bone plate and provoke
sporadic bone necrosis. In large animal condyles, bone cleanly removed
by Jamshidi biopsy or drilling is slow to repair with mineralized tissue.
2-mm diameter drill holes are resurfaced with soft repair tissue
whereas shallow microfracture holes have inadequate marrow com-
munication and are poorly resurfaced. Marrow stimulation surgical
approaches need to ﬁnd a balance between bone damage/blood vessel
rupture and subchondral implants that create optimal inﬂammatory
responses that elicit cell inﬂux and osteochondral repair.
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C. Sosio y, A. Di Giancamillo y, D. Deponti y, M. Agnoletto y, F. Gervaso z,
M. Domenicucci y, A. Addis x, M. Campagnol x, C. Domeneghini k,
A. Sannino z, G. Peretti{,y. y IRCCS Istituto Ortopedico Galeazzi, Milan,
Italy; zDept. of Engineering for Innovation, Univ. of Salento, Lecce, Italy;
x Istituto Sperimentale Italiano Lazzaro Spallanzani, Rivolta d’Adda (CR),
Italy; kDept. of Hlth., Animal Sci. and Food Safety, Univ. of Milan, Milan,
Italy; {Dept. of BioMed. Sci. for Hlth., Univ. of Milan, Milan, Italy
Purpose: The aim of this work is to validate the efﬁcacy of a tissue
engineered osteochondral composite for the treatment of cartilage
lesion produced in adult pigs. The osteochondral composite was man-
ufactured by combining an osteo-compatible cylinder and a neo-
cartilagineous tissue obtained by seeding swine articular chondrocytes
into a collagen scaffold.
Methods: Articular cartilage was harvested from the trochlea of six
adult pigs and chondrocytes were isolated; after the in vitro expansion,
chondrocytes were seeded onto a collagen scaffold that was pre-inte-
grated in vitro to an osteo-compatible cylinder. The seeded osteo-
chondral scaffolds were cultured in chondrogenic medium for 3 weeks,
then they were surgically implanted in osteochondral lesions per-
formed in the trochlea of the same pigs from which the cartilage was
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with acellular scaffolds and others were left untreated. After 3 months,
the repair tissue of the three experimental groups was macroscopically
analyzed and processed for histological and biochemical analysis.
Results: The histologic ICRS II scale showed a statistically signiﬁcant
difference between the three experimental groups only in the param-
eters regarding the cell morphology and the surface/superﬁcial
assessment: the lesion treated with the unseeded osteochondral scaf-
folds showed higher values in chondrocytes morphology and in the
superﬁcial layer recovery, with respect to the lesions treated with the
seeded scaffolds or left untreated. The biochemical analysis showed a
higher DNA content in the lesion repaired with cellular scaffold and a
higher GAGs/DNA ratio in the lesions with a spontaneous repair
Conclusions: This osteochondral scaffold was able to repair an osteo-
chondral lesion in an in vivo model, showing a good integration with
the surrounding tissue. The quality of the repair was higher when the
scaffold was not seeded with chondrocytes, but ﬁlled with cells
migrated from subchondral bone. This tissue engineered osteochondral
composite could represent a valuable model for further in vivo studies
on the repair of chondral/osteochondral lesion.
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Purpose: Osteochondral autograft transplantation (OAT) is a common
procedure for the treatment of focal articular defects. Multiple factors
likely inﬂuence the effectiveness of this procedure, including the source
of donor cartilage, health of cartilage surrounding the defect site, and
ultimately the degree to which integration occurs at the interface with
native tissue. In animal models and in vitro experiments it has been
shown that Sprifermin (recombinant human FGF18, rhFGF18) promotes
chondrocyte proliferation and extra-cellular matrix (ECM) biosynthesis,
and stimulates cartilage repair. Since in many instances OAT procedures
result in poor integration (due to low cellularity and ﬁbrous tissue
formation at the interface), we tested the hypothesis that addition of
Sprifermin would increase cartilage-to-cartilage integration by
increasing cell proliferation and ECM accumulation at the interface. We
tested this hypothesis in an in vitro cartilage explant injury model and
evaluated outcomes using mechanical, histological, and micro-com-
puted tomography (mCT) assays of the interface.
Methods: Fresh hyaline cartilage was harvested from the trochlear
groove of juvenile bovine knees (3-6 months old). Cylindrical explants
(8mm, Fig 1A) were removed with a biopsy punch and cultured over-
night in complete medium. Samples were trimmed of bone and defects
(4mm diameter) were created to form a core and annulus repair con-
struct (Fig 1B). Both the inner core and outer annulus were cultured
separately for 24 hours before the defect was ﬁlled with the original
core.
Figure 1. Preparation of cartilage-defect repair model: (A) 8mm cartilage
plug, (B) central 4mm defect creation, (C) insertion of cartilage into defect,
and (D) long term culture of repair construct.
Samples were then cultured in complete medium, or treated with
Sprifermin (rhFGF18, 100 ng/ml). Treatments consisted of one dose of
rhFGF18 for 24 hours, applied once aweek (and repeated weekly) (1þ6)
or one 24 hour treatment followed by 1 month of culture in complete
medium (1þ30 days). Samples were harvested after 4 weeks of culture.
Integration strength was evaluated through push-out mechanical
testing using an Instron 5848 and a custom testing rig (Fig 2E). For 3D
visualization, samples were soaked in a modiﬁed Lugol’s solution for 24
hours and scanned by mCT. Scans were analyzed and reconstructed
using the manufacturer’s software, and cross sections were used to
evaluate defect integration. Additional samples were ﬁxed overnight in
4% PFA and analyzed histologically for cell and matrix deposition at the
interface.Figure 2. (A-C) Transverse cross sections of 3D mCT reconstruction with
different treatments. (D) Integration strength of the repaired defect
showing increasing strength from the control to the 1þ30 treatment to
the 1þ6 treatment. (E) Experimental setup of the push-out testing rig.
Error bars are SEM.
Results: The integration strength (Fig 2D) of control samples was the
lowest (5.0 2.9 kPa), with progressively increasing properties with the
1þ30 (10.0  4.7 kPa) and 1þ6 (20.4  7.3 kPa) treatments. While the
results are striking when comparing controls and treated groups, with
the replicate numbers possible in this study, statistical signiﬁcance was
not achieved.
mCT analysis of control constructs (Fig 3, top left) showed a distinct dark
circle, indicating separation between the outer annulus and inner core,
and thus poor integration. The 1þ30 treatment (Fig 3, middle left)
showed a less distinct circle, suggesting a smaller gap and greater inte-
gration, and the 1þ6 treatment (Fig 3, bottom left) showed very homo-
genous mCTsignal across the interface, indicative of the greatest degree of
integration. Evidence of this increased integrationwas apparent on both
vertical and transverse cross sections throughout the samples.
Figure 3. mCT scans of cartilage-to-cartilage repair constructs. Left: single
mCT scan slice representative of the sample. Center: three dimensional
reconstruction. Right: cross-section of the reconstruction. The mCT scans
demonstrate increasing integration from control to 1þ30 to 1þ6
treatments.
